Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 298, Issue 2, 2010, Pages

  Stauffer, Brian L ^a,b,c   Westby, Christian M ^a   Greiner, Jared J ^a   Van Guilder, Gary P ^a   Desouza, Christopher A ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

Endothelin receptor antagonist; Endothelin 1; Endothelium; Sex differences; Vascular function

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE;

ADULT; AGED; BODY MASS; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY DILATATION; FEMALE; FOREARM BLOOD FLOW; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; VASOCONSTRICTION; VEIN OCCLUSION PLETHYSMOGRAPHY;

AGED; BODY COMPOSITION; BODY MASS INDEX; ENDOTHELIN-1; FEMALE; FOREARM; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIPIDS; MALE; MIDDLE AGED; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PIPERIDINES; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; REGIONAL BLOOD FLOW; SEX CHARACTERISTICS; VASOCONSTRICTOR AGENTS;

EID: 75449107728     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00626.2009     Document Type: Conference Paper

References (45)

1. American Heart Association. Heart Disease and Stroke Statistics: 2005 Update, http://www.americanheart.org, 2005.
2. Ammar EM, Said SA, Hassan MS. Enhanced vasoconstriction and reduced vasorelaxation induced by testosterone and nandrolone in hypercholesterolemic rabbits. Pharmacol Res 50: 253-259, 2004.
3. Ammarguellat FZ, Gannon PO, Amiri F, Schiffrin EL. Fibrosis, matrix metalloproteinases, and inflammation in the heart of DOCA-salt hypertensive rats: role of ET(A) receptors. Hypertension 39: 679-684, 2002.
4. Bax WA, Bruinvels AT, van Suylen RJ, Saxena PR, Hoyer D. Endothelin receptors in the human coronary artery, ventricle and atrium. A quantitative autoradiographic analysis. Naunyn Schmiedebergs Arch Pharmacol 348: 403-410, 1993.
5. Cardillo C, Campia U, Bryant MB, Panza JA. Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation 106: 1783-1787, 2002.
6. Cardillo C, Campia U, Kilcoyne CM, Bryant MB, Panza JA. Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension. Circulation 105: 452-456, 2002.
7. Cardillo C, Kilcoyne CM, Cannon RO, 3rd, Panza JA. Increased activity of endogenous endothelin in patients with hypercholesterolemia. J Am Coll Cardiol 36: 1483-1488, 2000.
8. Cardillo C, Kilcoyne CM, Waclawiw M, Cannon RO, 3rd, Panza JA. Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension 33: 753-758, 1999.
9. Dashwood MR, Tsui JC. Endothelin-1 and atherosclerosis: potential complications associated with endothelin-receptor blockade. Atherosclerosis 160: 297-304, 2002.
10. DeSouza CA, Clevenger CM, Greiner JJ, Smith DT, Hoetzer GL, Shapiro LF, Stauffer BL. Evidence for agonist-specific endothelial vasodilator dysfunction with ageing in healthy humans. J Physiol 542: 255-262, 2002.
11. 2+ signaling". Am J Physiol Cell Physiol 277: C614-C615, 1999.
12. Evans NJ, Walker JW. Endothelin receptor dimers evaluated by FRET, ligand binding, and calcium mobilization. Biophys J 95: 483-492, 2008.
13. Godfraind T. Evidence for heterogeneity of endothelin receptor distribution in human coronary artery. Br J Pharmacol 110: 1201-1205, 1993.
14. Gregan B, Jurgensen J, Papsdorf G, Furkert J, Schaefer M, Beyermann M, Rosenthal W, Oksche A. Ligand-dependent differences in the internalization of endothelin A and endothelin B receptor heterodimers. J Biol Chem 279: 27679-27687, 2004.
15. Guarda E, Katwa LC, Myers PR, Tyagi SC, Weber KT. Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc Res 27: 2130-2134, 1993.
16. Harada N, Himeno A, Shigematsu K, Sumikawa K, Niwa M. Endothelin-1 binding to endothelin receptors in the rat anterior pituitary gland: possible formation of an ETA-ETB receptor heterodimer. Cell Mol Neurobiol 22: 207-226, 2002.
17. Hong HJ, Liu JC, Chan P, Juan SH, Loh SH, Lin JG, Cheng TH. 17β-estradiol downregulates angiotensin-II-induced endothelin-1 gene expression in rat aortic smooth muscle cells. J Biomed Sci 11: 27-36, 2004.
18. Ihling C, Szombathy T, Bohrmann B, Brockhaus M, Schaefer HE, Loeffler BM. Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis. Circulation 104: 864-869, 2001.
19. Juan SH, Chen JJ, Chen CH, Lin H, Cheng CF, Liu JC, Hsieh MH, Chen YL, Chao HH, Chen TH, Chan P, Cheng TH. 17β-estradiol inhibits cyclic strain-induced endothelin-1 gene expression within vascular endothelial cells. Am J Physiol Heart Circ Physiol 287: H1254-H1261, 2004.
20. Kelly JJ, Whitworth JA. Endothelin-1 as a mediator in cardiovascular disease. Clin Exp Pharmacol Physiol 26: 158-161, 1999.
21. Kitsukawa Y, Gu ZF, Hildebrand P, Jensen RT. Gastric smooth muscle cells possess two classes of endothelin receptors but only one alters contraction. Am J Physiol Gastrointest Liver Physiol 266: G713-G721, 1994.
22. Lavallee M, Takamura M, Parent R, Thorin E. Crosstalk between endothelin and nitric oxide in the control of vascular tone. Heart Fail Rev 6: 265-276, 2001.
23. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 325: 997-1001, 1991.
24. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: e21-e181, 2009.
25. Maguire JJ, Davenport AP. ETA receptor-mediated constrictor responses to endothelin peptides in human blood vessels in vitro. Br J Pharmacol 115: 191-197, 1995.
26. Miyauchi T, Masaki T. Pathophysiology of endothelin in the cardiovascular system. Annu Rev Physiol 61: 391-415, 1999.
27. Newby DE, Wright RA, Labinjoh C, Ludlam CA, Fox KAA, Boon NA, Webb DJ. Endothelial dysfunction, impaired endogenous fibrinolysis and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation 99: 1411-1415, 1999.
28. Newby DE, Wright RA, Labinjoh C, Ludlam CA, Fox KA, Boon NA, Webb DJ. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation 99: 1411-1415, 1999.
29. Pearson LJ, Yandle TG, Nicholls MG, Evans JJ. Regulation of endothelin-1 release from human endothelial cells by sex steroids and angiotensin-II. Peptides 29: 1057-1061, 2008.
30. Pierre LN, Davenport AP. Endothelin receptor subtypes and their functional relevance in human small coronary arteries. Br J Pharmacol 124: 499-506, 1998.
31. Pierre LN, Davenport AP. Relative contribution of endothelin A and endothelin B receptors to vasoconstriction in small arteries from human heart and brain. J Cardiovasc Pharmacol 31 Suppl 1: S74-S76, 1998.
32. Ravalli S, Szabolcs M, Albala A, Michler RE, Cannon PJ. Increased immunoreactive endothelin-1 in human transplant coronary artery disease. Circulation 94: 2096-2102, 1996.
33. Rossi GP, Colonna S, Pavan E, Albertin G, Della Rocca F, Gerosa G, Casarotto D, Sartore S, Pauletto P, Pessina AC. Endothelin-1 and its mRNA in the wall layers of human arteries ex vivo. Circulation 99: 1147-1155, 1999.
34. Saetrum Opgaard O, Adner M, Gulbenkian S, Edvinsson L. Localization of endothelin immunoreactivity and demonstration of constrictory endothelin-A receptors in human coronary arteries and veins. J Cardiovasc Pharmacol 23: 576-583, 1994.
35. Schiffrin EL. Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens 14: 83S-89S, 2001.
36. Schiffrin EL. Vascular endothelin in hypertension. Vascul Pharmacol 43: 19-29, 2005.
37. Teerlink JR, Breu V, Sprecher U, Clozel M, Clozel JP. Potent vasoconstriction mediated by endothelin ETB receptors in canine coronary arteries. Circ Res 74: 105-114, 1994.
38. Teoh H, Quan A, Leung SW, Man RY. Differential effects of 17β-estradiol and testosterone on the contractile responses of porcine coronary arteries. Br J Pharmacol 129: 1301-1308, 2000.
39. Tostes RC, Touyz RM, He G, Ammarguellat F, Schiffrin EL. Endothelin A receptor blockade decreases expression of growth factors and collagen and improves matrix metalloproteinase-2 activity in kidneys from stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 39: 892-900, 2002.
40. Touyz RM, Schiffrin EL. Role of endothelin in human hypertension. Can J Physiol Pharmacol 81: 533-541, 2003.
41. Van Guilder GP, Westby CM, Greiner JJ, Stauffer BL, DeSouza CA. Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise. Hypertension 50: 403-409, 2007.
42. van Harmelen V, Eriksson A, Astrom G, Wahlen K, Naslund E, Karpe F, Frayn K, Olsson T, Andersson J, Ryden M, Arner P. Vascular peptide endothelin-1 links fat accumulation with alterations of visceral adipocyte lipolysis. Diabetes 57: 378-386, 2008.
43. Wang X, Barber DA, Lewis DA, McGregor CG, Sieck GC, Fitzpatrick LA, Miller VM. Gender and transcriptional regulation of NO synthase and ET-1 in porcine aortic endothelial cells. Am J Physiol Heart Circ Physiol 273: H1962-H1967, 1997.
44. Webb CM, Ghatei MA, McNeill JG, Collins P. 17β-estradiol decreases endothelin-1 levels in the coronary circulation of postmenopausal women with coronary artery disease. Circulation 102: 1617-1622, 2000.
45. Wilbert-Lampen U, Seliger C, Trapp A, Straube F, Plasse A. Female sex hormones decrease constitutive endothelin-1 release via endothelial sigma-1/cocaine receptors: an action independent of the steroid hormone receptors. Endothelium 12: 185-191, 2005.